4:28 PM
 | 
Jun 17, 2016
 |  BC Extra  |  Clinical News

NIH to review first human use of CRISPR gene editing

NIH's Office of Science Policy said the agency's Recombinant DNA Advisory Committee (RAC) will meet June 21-22 to discuss a proposed Phase I trial using CRISPR/ Cas9 gene editing as part of a chimeric antigen receptor (CAR) T cell therapy. NIH said the study...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >